Skip to main content

Advertisement

Log in

Oral and Maxillofacial Neuroendocrine Carcinoma: A Systematic Review

  • Review
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

The aim of the present study was to integrate the available data published in the literature on oral and maxillofacial neuroendocrine carcinomas concerning the demographic, clinical and histopathological features of this condition. An electronic search with no publication date restriction was undertaken in April 2021 in four databases. Eligibility criteria included reports published in English having enough data to confirm a definite diagnosis, always showing a neuroendocrine marker. Cases originating in the oropharynx, including base of the tongue and tonsils, were excluded. Outcomes were evaluated by the Kaplan–Meier method along with Cox regression. Twenty-five articles (29 cases) from nine different countries were detected. Mean patient age was 56.3 (± 17.5) years, with a slight male predilection. Symptomatology was present in 72.2% of informed cases. Regarding clinical presentation, a non-ulcerated nodule located in the gingiva with a mean size of 3.4 (± 2.0) cm was most frequently reported. Concomitant metastasis was identified in seven individuals. Histopathologically, most neoplasms were of the small cell type, and immunohistochemistry for both epithelial and neuroendocrine differentiation was used in 65.5% cases. Radical surgery was the treatment of choice in almost all cases, with or without adjuvant therapy. Mean follow-up was 20.5 (± 21.2) months, and only four patients developed recurrences. Eleven (44.0%) individuals died due to the disease. Ulcerated lesions were a prognostic factor. This study provides knowledge that can assist surgeons, oncologists, and oral and maxillofacial pathologists with the diagnosis and management of neuroendocrine carcinomas. Our findings demonstrated that the long-term prognosis of this lesion continues to be poor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

None.

Code availability

None.

References

  1. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. World Health Organization classification of head and neck tumours. 4th ed. Lyon: IARC Press; 2017.

    Google Scholar 

  2. Gadducci A, Carinelli S, Aletti G. Neuroendrocrine tumors of the uterine cervix: a therapeutic challenge for gynecologic oncologists. Gynecol Oncol. 2017;144:637–46.

    Article  PubMed  Google Scholar 

  3. Oberndorfer S. Karzenoide tumoren des dünndarms. Frankf Z Pathol. 1907;1:426–32.

    Google Scholar 

  4. Öberg K. The Genesis of the Neuroendocrine Tumors Concept: From Oberndorfer to 2018. Endocrinol Metab Clin North Am. 2018;47:711–31.

    Article  PubMed  Google Scholar 

  5. Ferlito A. The World Health Organization’s revised classification of tumours of the larynx, hypopharynx, and trachea. Ann Otol Rhinol Laryngol. 1993;102:666–9.

    Article  CAS  PubMed  Google Scholar 

  6. Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol. 2002;15:264–78.

    Article  PubMed  Google Scholar 

  7. Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31:1770–86.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Benzerdjeb N, Traverse-Glehen A, Philouze P, Bishop J, Devouassoux-Shisheboran M. Poorly differentiated neuroendocrine carcinoma of the head and neck: human papillomavirus tumour status/p16 status and impact on overall survival. Histopathology. 2020;76:581–91.

    Article  PubMed  Google Scholar 

  9. Meacham R, Matrka L, Ozer E, Ozer HG, Wakely P, Shah M. Neuroendocrine carcinoma of the head and neck: a 20-year case series. Ear Nose Throat J. 2012;91:E20–4.

    Article  PubMed  Google Scholar 

  10. Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z (eds.) JBI Manual for Evidence Synthesis. JBI, 2020. Available from https://synthesismanual.jbi.global.

  11. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:71.

    Article  Google Scholar 

  12. Hayashi Y, Nagamine S, Yanagawa T, Yoshida H, Yura Y, Azuma M, et al. Small cell undifferentiated carcinoma of the minor salivary gland containing exocrine, neuroendocrine, and squamous cells. Cancer. 1987;60:1583–8.

    Article  CAS  PubMed  Google Scholar 

  13. Yoshida H, Onizawa K, Hirohata H. Neuroendocrine carcinoma of the tongue: report of a case. J Oral Maxillofac Surg. 1995;53:823–7.

    Article  CAS  PubMed  Google Scholar 

  14. Kim SG, Jang HS. Small cell carcinoma of the oral cavity: report of a case. J Oral Maxillofac Surg. 2001;59:680–4.

    Article  CAS  PubMed  Google Scholar 

  15. Noguchi K, Urade M, Sakurai K, Nishimura N, Hashitani S, Kishimoto H. Small cell neuroendocrine carcinoma of the maxillary sinus: a case report and nude mouse transplantable model. Head Neck. 2002;24:491–6.

    Article  PubMed  Google Scholar 

  16. Oku N, Umeda M, Ri S, Takenono I, Ishii J, Komori T. A case of combined large cell neuroendocrine carcinoma of the lower gingiva associated with focal differentiation to squamous cell carcinoma. Jpn J Oral Maxillofac Surg. 2002;48:12–5.

    Article  Google Scholar 

  17. Güler N, Yumuk PF, Ilguy D, Olgac V, Greer J. Limited painful mouth opening. J Oral Maxillofac Surg. 2005;63:1201–5.

    Article  PubMed  Google Scholar 

  18. Tarozzi M, Demarosi F, Lodi G, Sardella A, Carrassi A. Primary small cell carcinoma of the nasal cavity with an unusual oral manifestation. J Oral Pathol Med. 2007;36:252–4.

    Article  PubMed  Google Scholar 

  19. Nishihara K, Nozoe E, Hirayama Y, Miyawaki A, Semba I, Nakamura N. A case of small cell carcinoma in the buccal region. Int J Oral Maxillofac Surg. 2009;38:1000–3.

    Article  CAS  PubMed  Google Scholar 

  20. Mochizuki Y, Omura K, Sakamoto K, Nakanishi S, Satoh K, Marukawa E, Yamaguchi A. A case of primary combined neuroendocrine carcinoma with squamous cell carcinoma in the upper gingiva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:e34–9.

    Article  PubMed  Google Scholar 

  21. Chen Y, Wang C, Wang HM, Li J, Zhu HY. Primary small cell carcinoma with neuroendocrine properties of the mandible: a case report and literature review. J Dent Sci. 2017;12:413–6.

    Article  PubMed  Google Scholar 

  22. Cymerman JA, Kulkarni R, Gouldesbrough D, McCaul J. Small cell neuroendocrine tumour of the anterior tongue: A case report. Int J Surg Case Rep. 2013;4:753–5.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Terada T. Small cell carcinoma of the oral cavity (cheek mucosa): a case report with an immunohistochemical and molecular genetic analysis. Int J Clin Exp Pathol. 2013;6:780–7.

    PubMed  PubMed Central  Google Scholar 

  24. Yoshino Y, Akiyama S, Ouchi K, Oishi T, Takahashi H, Lee J, et al. Acute exacerbation of paraneoplastic neurological syndrome after massive tumor lysis of neuroendocrine carcinoma by chemoradiotherapy. Int Canc Conf J. 2013;2:247–50.

    Article  Google Scholar 

  25. Bothara R, Raval R, Kapoor A. Large cell poorly differentiated neuroendocrine carcinoma of the maxilla: an extremely rare tumor. IJSS Case Rep Rev. 2004;1:22–4.

    Google Scholar 

  26. Singla A, Singla A, Gallagher R. A rare case and literature review of primary neuroendocrine carcinoma of the tongue. J Surg Case Rep. 2014;22:084.

    Google Scholar 

  27. Wu BZ, Gao Y, Yi B. Primary neuroendocrine carcinoma in oral cavity: two case reports and review of the literature. J Oral Maxillofac Surg. 2014;72:633–44.

    Article  PubMed  Google Scholar 

  28. Esmati E, Babaei M, Matini A, Ashtiani MS, Hamed EA, Nosrati H, Razi F, Ganjalikhani M. Neuroendocrine carcinoma of the tongue. J Cancer Res Ther. 2015;11(3):659.

    Article  PubMed  Google Scholar 

  29. Gumusay O, Yilmaz G, Aydil U, Ozet A, Tufan G, Erdem O, Kizil Y, Benekli M. Small cell neuroendocrine carcinoma of the posterior tongue. J Cancer Res Ther. 2015;11(3):651.

    Article  PubMed  Google Scholar 

  30. Hamamoto T, Fujii S, Miyazaki M, Shinozaki T, Tomioka T, Hayashi R. Nine cases of carcinoma with neuroendocrine features in the head and neck: clinicopathological characteristics and clinical outcomes. Jpn J Clin Oncol. 2015;45:328–35.

    Article  PubMed  Google Scholar 

  31. Zeng M, Yang SD, Zhang JL, Chen XM. Primary small cell neuroendocrine carcinoma of the oral cavity: a case report and review of the literature. Oncol Lett. 2015;10(2):887–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Sase M, Itoh H, Hayasaka J, Hoshi K, Noguchi T, Jinbu Y, et al. Small cell carcinoma in the palatal mucosa: a case report. J Oral Maxillofac Surg Med Pathol. 2016;28:493–7.

    Article  Google Scholar 

  33. Deyhimi P, Razavi M, Hoseini AT, Alishahi B. Small cell neuroendocrine carcinoma of the salivary glands of the palate: report of a rare case and a review of the literature. Avicenna J Dent Res. 2017;9:e33366.

    Article  Google Scholar 

  34. Udompatanakorn C, Yada N, Ishikawa A, Miyamoto I, Sato Y, Matsuo K. Primary neuroendocrine carcinoma combined with squamous cell carcinoma of the soft palate: a case report and review of literature. Open J Stomatol. 2018;8:90–9.

    Article  Google Scholar 

  35. Olivetto M, Bettoni J, Testelin S, Dakpé S. Small cell carcinoma of the floor of mouth: difficulties of a therapeutic choice. J Stomatol Oral Maxillofac Surg. 2019;120:255–9.

    Article  CAS  PubMed  Google Scholar 

  36. Neftah C, Ayouche O, El Bakkari A, Omor Y, Latib R. A rare occurrence of neuroendocrine carcinoma: case report and review of the literature. Int J Recent Adv Multidiscip Res. 2020;7:6153–6.

    Google Scholar 

  37. Huang D, Peng Y, Xiong H, Hu X, Wang C, Wang Z, et al. Primary poorly differentiated neuroendocrine carcinoma of the oral cavity. Oral Dis 2021.

  38. Perez-Ordoñez B. Neuroendocrine carcinomas of the larynx and head and neck: challenges in classification and grading. Head Neck Pathol. 2018;12:1–8.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Sinno S, Assaad AM, Salem SN. Human papillomavirus-associated oropharyngeal high-grade neuroendocrine carcinoma in an adolescent: case report and review of literature. Clin Med Insights Pediatr. 2019;9(13):1179556519870520.

    Google Scholar 

  40. Strojan P, Hernandez-Prera JC, Beitler JJ, Eisbruch A, Saba NF, Mendenhall WM, et al. Small cell and large cell neuroendocrine carcinoma of the larynx: a comparative analysis. Cancer Treat Rev. 2019;78:42–51.

    Article  CAS  PubMed  Google Scholar 

  41. Ohmoto A, Sato Y, Asaka R, Fukuda N, Wang X, Urasaki T, Hayashi N, Sato Y, Nakano K, Yunokawa M, Ono M, Tomomatsu J, Toshiyasu T, Mitani H, Takeuchi K, Mori S, Takahashi S. Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma. Mod Pathol. 2021;34(11):1979–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Strosberg C, Ferlito A, Triantafyllou A, Gnepp DR, Bishop JA, Hellquist H. Update on neuroendocrine carcinomas of the larynx. Am Clin Pathol. 2019;152(6):686–700.

    Article  Google Scholar 

  43. Chu H, Shi Y, Liu J, Huang D, Zhang J, Dou C. Update in clinical management for gallbladder neuroendocrine carcinoma. Medicine (Baltimore). 2021;100(14):25449.

    Article  CAS  Google Scholar 

  44. Nielsen K, Binderup T, Langer SW, Kjaer A, Knigge P, Grøndahl V, et al. P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms. BMC Cancer. 2020;20:27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Westra WH. Human papillomavirus-related neuroendocrine carcinomas of the head and neck. Head Neck Pathol. 2018;12:9–12.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Rooper L, Sharma R, Bishop JA. Polymorphous low grade adenocarcinoma has a consistent p63+/p40- immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma. Head Neck Pathol. 2015;9:79–84.

    Article  PubMed  Google Scholar 

  47. Edwards PC, Bhuiya T, Kelsch RD. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:586–93.

    Article  PubMed  Google Scholar 

  48. Andreadis D, Epivatianos A, Poulopoulos A, Nomikos A, Papazoglou G, Antoniades D, et al. Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours. Oral Oncol. 2006;42:57–65.

    Article  CAS  PubMed  Google Scholar 

  49. Das DK. Contribution of immunocytochemistry to the diagnosis of usual and unusual lymphoma cases. J Cytol. 2018;35:163–9.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Bell D. Sinonasal neuroendocrine neoplasms: current challenges and advances in diagnosis and treatment, with a focus on olfactory neuroblastoma. Head Neck Pathol. 2018;12:22–30.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Ding J, Ji J, Zhu W. A retrospective study of different treatments of limited-stage small-cell esophageal carcinoma and associated prognostic factor analysis. Dis Esophagus. 2013;26:696–702.

    CAS  PubMed  Google Scholar 

  52. Gnepp DR, Ferlito A, Hyams V. Primary anaplastic small cell (oat cell) carcinoma of the larynx: review of the literature and report of 18 cases. Cancer. 1983;51:1731–45.

    Article  CAS  PubMed  Google Scholar 

  53. Yan O, Xie W, Teng H, Fu S, Chen Y, Liu F. Nomograms forecasting long-term overall and cancer specific survival of patients with head and neck neuroendocrine carcinoma. Front Oncol. 2021;11:619599.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank the Coordination for the Improvement of Higher Education Personnel (CAPES, Finance Code 001), Brazil. L.F.S. and L.B.K. are the recipients of fellowships. We also acknowledge the Brazilian National Council for Scientific and Technological Development (CNPq). F.P.F., J.N.S., P.A.V. and M.D.M. are research fellows of CNPq.

Funding

No funding obtained.

Author information

Authors and Affiliations

Authors

Contributions

Study concepts and Study design: LFS, MDM; Data acquisition: LFS, TRS, GOZ; Quality control of data and algorithms: LBK, FMS; Data analysis and interpretation and Manuscript preparation: LFS, VPW; Statistical analysis: VPW; Manuscript editing: MATM, RC, JNS, FPF; Manuscript review: PAV, MSM.

Corresponding author

Correspondence to Manoela Domingues Martins.

Ethics declarations

Conflict of interest

No conflict of interest to disclosure.

Ethical Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 14860 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schuch, L.F., Schmidt, T.R., de Oliveira Zigmundo, G. et al. Oral and Maxillofacial Neuroendocrine Carcinoma: A Systematic Review. Head and Neck Pathol 16, 525–537 (2022). https://doi.org/10.1007/s12105-021-01398-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-021-01398-2

Keywords

Navigation